A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.

MLA

Nishikawa, Koji, et al. “A Prospective Trial of Vaccine to Prevent Hepatitis B Virus Reactivation after Hematopoietic Stem Cell Transplantation.” Bone Marrow Transplantation, vol. 55, no. 7, July 2020, pp. 1388–98. EBSCOhost, https://doi.org/10.1038/s41409-020-0833-5.

APA

Nishikawa, K., Kimura, K., Kanda, Y., Sugiyama, M., Kakihana, K., Doki, N., Ohashi, K., Bae, S. K., Takahashi, K., Ishihara, Y., Mizuno, I., Onishi, Y., Onozawa, M., Onizuka, M., Yamamoto, M., Ishikawa, T., Inoue, K., Kusumoto, S., Hashino, S., … Mizokami, M. (2020). A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 55(7), 1388–1398. https://doi.org/10.1038/s41409-020-0833-5

Chicago

Nishikawa, Koji, Kiminori Kimura, Yoshinobu Kanda, Masaya Sugiyama, Kazuhiko Kakihana, Noriko Doki, Kazuteru Ohashi, et al. 2020. “A Prospective Trial of Vaccine to Prevent Hepatitis B Virus Reactivation after Hematopoietic Stem Cell Transplantation.” Bone Marrow Transplantation 55 (7): 1388–98. doi:10.1038/s41409-020-0833-5.